The cancer ‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma
ConclusionsThese results suggest that a combined Runx2/OPN expression could be a valuable independent predictor of tumor metastasis and survival in osteosarcoma patients.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Children | Osteosarcoma | Study